Star Scientific, Inc. Files Third-Quarter 10-Q Reporting on Financial Results, Continued Expansion of AnatablocÂ®  Dietary Supplement Sales, and IRB Approval for a Clinical Trial Relating to AnatablocÂ® Facial Creme